title: Update to South Asian consensus guideline: Use of newer insulins in diabetes during Ramadan Revised Guidelines on the use of insulin in Ramadan.
abstract: This guidance is an update to the South Asian Consensus Guideline: Use of Insulin in Diabetes during Ramadan, published in the Indian Journal of Endocrinology and Metabolism in 2012. A five country working group has collated evidence and experience to suggest guidelines for the safe and rational use of insulin degludec (IDeg) and insulin degludec aspart (IDegAsp) during Ramadan. The suggestions contained herewith are based on the pharmacokinetic and pharmacodynamics properties of these novel insulins.
authors.affiliation: Department of Endocrinology, Shaukhat Khanum Cancer Hospital and Research Center, Lahore, Pakistan.
authors.forename: Faruque
authors.initials: F
authors.lastname: Pathan
authors.affiliation: Director, BIRDEM, Dhaka, Bangladesh.
authors.forename: Zafar Ahmed
authors.initials: ZA
authors.lastname: Latif
authors.affiliation: Osmania Medical College, Hyderabad, India.
authors.forename: Rakesh Kumar
authors.initials: RK
authors.lastname: Sahay
authors.affiliation: Advanced Center for Diabetes and Endocrine Care, Srinagar, India.
authors.forename: Abdul Hamid
authors.initials: AH
authors.lastname: Zargar
authors.affiliation: Shaukhat Khanum Cancer Hospital and Research Center, Lahore, Pakistan.
authors.forename: Syed Abbas
authors.initials: SA
authors.lastname: Raza
authors.affiliation: Diabetes Association of Bangladesh.
authors.forename: A K Azad
authors.initials: AK
authors.lastname: Khan
authors.affiliation: Mymensingh Medical College, Mymensingh, Bangladesh.
authors.forename: Nazrul Islam
authors.initials: NI
authors.lastname: Siddiqui
authors.affiliation: Department of Endocrinology, Shaukhat Khanum Cancer Hospital and Research Center, Lahore, Pakistan.
authors.forename: Feroz
authors.initials: F
authors.lastname: Amin
authors.affiliation: Department of Endocrinology, Shifa International Hospital, Islamabad, Pakistan.
authors.forename: Osama
authors.initials: O
authors.lastname: Ishtiaq
authors.affiliation: Department of Endocrinology, Norvic International Hospital, Kathmandu, Nepal.
authors.forename: Dina
authors.initials: D
authors.lastname: Shrestha
authors.affiliation: Diabetes and Endocrine Unit, National Hospital, Colombo, Sri Lanka.
authors.forename: Noel
authors.initials: N
authors.lastname: Somasundaram
authors.affiliation: Department of Endocrinology, Bharti Hospital and BRIDE, Karnal, Haryana, India.
authors.forename: Sanjay
authors.initials: S
authors.lastname: Kalra
mesh_terms: D001786:Blood Glucose; D003920:Diabetes Mellitus / Q000188:drug therapy; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D005215:Fasting; D006442:Glycated Hemoglobin; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007328:Insulin / Q000627:therapeutic use*; D061267:Insulin Aspart; D007514:Islam; D017410:Practice Guidelines as Topic
chemical_list: D001786:Blood Glucose; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D007328:Insulin; D061267:Insulin Aspart
keywords: Aspart, Degludec, Degludec aspart, Diabetes, Hypoglycaemia, Insulin, Ramadan.